Universa Medicina (UnivMed) is an official scientific publication of the Faculty of Medicine Universitas Trisakti and is a peer-reviewed open-access journal. Universa Medicina is a four-monthly medical journal that publishes new research findings on a wide variety of topics of importance to biomedical science and clinical practice. Universa Medicina is a general medical journal that focuses on all aspects of human health.
Accredited journal based on Ministerial Decree of the Minister of Research and Technology / Head of National Research and Innovation Agency of the Republic of Indonesia with First Grade (Peringkat 1, Sinta 1, Garuda) No. 148/M/KPT/2020 Volume 38 Number 3, 2019 to Volume 43 Number 2, 2024.
The Univ Med journal has been indexed and abstracted and displayed in Clarivate Analytics Web of Science Core Collection Database (Emerging Source Citation Index) (Q4 JCR), Dimensions-Digital Science, CABI, ASEAN Citation Index, DOAJ, Chemical Abstract Services (CAS), ROAD, National Library of Medicine, ICMJE, ICI, and SINTA.
Current Issue
Vol. 44 No. 1 (2025): Ahead Of Print
Published: 2025-01-31
Editorial
Robotic-assisted total knee replacement: pioneering precision and the future of joint reconstruction
- 1-2
- abstract viewed: 73
- PDF: 42
Original Articles
In-hospital mortality and its determinant factors among patients with sepsis
- 3-15
- abstract viewed: 102
- PDF: 65
Assessment of nurses’ knowledge about therapeutic play in pediatric services of a training and research hospital
- 16-25
- abstract viewed: 51
- PDF: 32
Effects of aging on colony count and antibiotic susceptibility patterns of Escherichia coli isolated from male Wistar rats
- 34-42
- abstract viewed: 57
- PDF: 31
Discordance of HER2 between primary tumors and lymph node metastatic lesions in invasive breast cancer
- 43-49
- abstract viewed: 56
- PDF: 28
Effect of the family medicine approach in reducing stunting among toddlers
- 50-56
- abstract viewed: 64
- PDF: 30
HIV‑1 drug‑resistance mutations and related risk factors among HIV‑1‑positive individuals receiving first-line antiretroviral therapy
- 57-64
- abstract viewed: 23
- PDF: 12